NEOGENOMICS INC — Director's Dealing 2019

Aug 30, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2019-08-28

Reporting Person: JONES STEVEN C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-08-28	Common Stock	S	39537	$25.02	Disposed	1679124	Indirect
2019-08-30	Common Stock	S	1200	$25	Disposed	1677924	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	150000	Indirect
Common Stock	47657	Indirect
Common Stock	245234	Direct
Common Stock	50476	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$4.78	2020-05-04	Common Stock (225000.0)	225000	Direct
Stock Option (Right to Buy)	$7.15	2021-04-20	Common Stock (100000.0)	100000	Direct
Stock Option (Right to Buy)	$7.27	2022-05-25	Common Stock (10000.0)	10000	Direct
Stock Option (Right to Buy)	$11.6	2023-06-01	Common Stock (3017.0)	3017	Direct
Stock Option (Right to Buy)	$22.52	2026-06-06	Common Stock (4269.0)	4269	Direct

Footnotes

F1: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein.

F2: On May 4, 2015, Mr. Jones was granted 225,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.

F3: On April 20, 2016, Mr. Jones was granted 100,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.

F4: On May 25, 2017, Mr. Jones was granted 10,000 stock options. The options vest ratably on the next three anniversary dates of the grant date.